Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ATAC-seq from Nutlin-3a-treated MCF-7 cells

ABSTRACT: ATAC-seq from Nutlin-3a-treated MCF-7 cells

PROVIDER: PRJNA1051614 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR27190528_1.fastq.gz	Fastqsanger.gz
	SRR27190528_2.fastq.gz	Fastqsanger.gz
	SRR27190529_1.fastq.gz	Fastqsanger.gz
	SRR27190529_2.fastq.gz	Fastqsanger.gz
	SRR27190530_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

ATAC-seq from Nutlin-3a-treated MCF-7 cells

Project description:ATAC-seq from MCF-7 cells treated with Nutlin-3a or DMSO control

2024-09-18 | GSE250017 | GEO

Nanopore long-read sequencing from Nutlin-3a-treated MCF-7 cells

Project description:Nanopore long-read sequencing from MCF-7 cells treated with Nutlin-3a or DMSO control

2024-09-18 | GSE226080 | GEO

QuantSeq from Nutlin-3a-treated MCF-7, U2OS, and RPE-1 cells

Project description:QuantSeq from MCF-7, U2OS, and RPE-1 cells treated with Nutlin-3a or DMSO control

2024-09-18 | GSE223513 | GEO

CAGE-seq from Nutlin-3a-treated MCF-7, U2OS, and RPE-1 cells

Project description:CAGE-seq from MCF-7, U2OS, and RPE-1 cells treated with Nutlin-3a or DMSO control

2024-09-18 | GSE223512 | GEO

Nutlin-3a induced changes in the transcriptome of MCF-7 cells

Project description:RNA-seq from MCF-7 cells treated with Nutlin-3a or DMSO control

2024-09-18 | GSE216721 | GEO

Nanopore long-read sequencing from Nutlin-3a-treated MCF-7 cells

Project description:Nanopore long-read sequencing from Nutlin-3a-treated MCF-7 cells

| PRJNA938478 | ENA

QuantSeq from Nutlin-3a-treated MCF-7, U2OS, and RPE-1 cells

Project description:QuantSeq from Nutlin-3a-treated MCF-7, U2OS, and RPE-1 cells

| PRJNA926620 | ENA

Expression data from human sarcoma patient samples treated with either vehicle control or Nutlin-3a

Project description:This study has examined the molecular mechanisms underlying sensitivity of sarcomas to Nutlin-3a, a non-genotoxic activator of the p53 pathway. Human patient material was collected immediately following surgical resection, dissected into small pieces and ex planted onto gelatin sponges immersed in media containing either vehicle control or Nutlin-3a (10uM and/or 50uM) for 48 hours. Nutlin-3a represents a novel targeted therapy for the treatment of sarcomas. We have examined expression profiles of genes upregulated in sarcoma patient derived tissues following nutlin-3a treatment ex vivo 16 samples ((Vehicle control and Nutlin-3a (10uM and 50uM) treated samples)) from 6 sarcoma patients

2014-03-10 | E-GEOD-48296 | biostudies-arrayexpress

CAGE-seq from Nutlin-3a-treated MCF-7, U2OS, and RPE-1 cells

Project description:CAGE-seq from Nutlin-3a-treated MCF-7, U2OS, and RPE-1 cells

| PRJNA926621 | ENA

mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells

Project description:We sequenced mRNA from HCT116 p21-/- cells treated with Nutlin-3a, doxorubicin, or DMSO for 24 h.

2016-06-09 | GSE77841 | GEO